| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |